Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof
US-9226974-B2 · Jan 5, 2016 · US
Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof
US9580467B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9580467-B2 |
| Application number | US-201514939547-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 12, 2015 |
| Priority date | Aug 3, 2009 |
| Publication date | Feb 28, 2017 |
| Grant date | Feb 28, 2017 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Antiproliferative compounds having a structure represented by formula (II), where n, R 1 , R 2 , R 3 , R 4 , and R 5 are as defined herein, can be used to treat tumors, optionally when conjugated to a ligand such as an antibody:
First claim
Opening claim text (preview).
What is claimed is: 1. A compound having a structure according to formula (VI-t)
Assignees
Inventors
Classifications
Antineoplastic agents · CPC title
specific for metastasis · CPC title
specific for leukemia · CPC title
Tripeptides · CPC title
to carbon atoms of carbon skeletons containing rings · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9580467B2 cover?
- Antiproliferative compounds having a structure represented by formula (II), where n, R 1 , R 2 , R 3 , R 4 , and R 5 are as defined herein, can be used to treat tumors, optionally when conjugated to a ligand such as an antibody:
- Who is the assignee on this patent?
- Squibb & Sons Llc
- What technology area does this patent fall under?
- Primary CPC classification C07K7/06. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Feb 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).